Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 903

1.

Celecoxib induces hepatic stellate cell apoptosis through inhibition of Akt activation and suppresses hepatic fibrosis in rats.

Paik YH, Kim JK, Lee JI, Kang SH, Kim DY, An SH, Lee SJ, Lee DK, Han KH, Chon CY, Lee SI, Lee KS, Brenner DA.

Gut. 2009 Nov;58(11):1517-27. doi: 10.1136/gut.2008.157420. Epub 2009 Feb 6.

PMID:
19201774
3.

Ursolic acid ameliorates hepatic fibrosis in the rat by specific induction of apoptosis in hepatic stellate cells.

Wang X, Ikejima K, Kon K, Arai K, Aoyama T, Okumura K, Abe W, Sato N, Watanabe S.

J Hepatol. 2011 Aug;55(2):379-87. doi: 10.1016/j.jhep.2010.10.040. Epub 2010 Dec 17.

PMID:
21168456
4.

Icaritin induces cell death in activated hepatic stellate cells through mitochondrial activated apoptosis and ameliorates the development of liver fibrosis in rats.

Li J, Liu P, Zhang R, Cao L, Qian H, Liao J, Xu W, Wu M, Yin Z.

J Ethnopharmacol. 2011 Sep 1;137(1):714-23. doi: 10.1016/j.jep.2011.06.030. Epub 2011 Jun 24.

PMID:
21726622
5.

Antifibrotic effects of magnesium lithospermate B on hepatic stellate cells and thioacetamide-induced cirrhotic rats.

Paik YH, Yoon YJ, Lee HC, Jung MK, Kang SH, Chung SI, Kim JK, Cho JY, Lee KS, Han KH.

Exp Mol Med. 2011 Jun 30;43(6):341-9.

6.

The anti-inflammatory effect of celecoxib does not prevent liver fibrosis in bile duct-ligated rats.

Yu J, Hui AY, Chu ES, Go MY, Cheung KF, Wu CW, Chan HL, Sung JJ.

Liver Int. 2009 Jan;29(1):25-36. doi: 10.1111/j.1478-3231.2008.01760.x. Epub 2008 Apr 23.

PMID:
18435714
7.

Study on antifibrotic effects of curcumin in rat hepatic stellate cells.

Lin YL, Lin CY, Chi CW, Huang YT.

Phytother Res. 2009 Jul;23(7):927-32. doi: 10.1002/ptr.2764.

PMID:
19152370
8.

Effect of celecoxib on experimental liver fibrosis in rat.

Hui AY, Leung WK, Chan HL, Chan FK, Go MY, Chan KK, Tang BD, Chu ES, Sung JJ.

Liver Int. 2006 Feb;26(1):125-36.

PMID:
16420518
9.

Bile acids induce hepatic stellate cell proliferation via activation of the epidermal growth factor receptor.

Svegliati-Baroni G, Ridolfi F, Hannivoort R, Saccomanno S, Homan M, De Minicis S, Jansen PL, Candelaresi C, Benedetti A, Moshage H.

Gastroenterology. 2005 Apr;128(4):1042-55.

PMID:
15825085
10.

New insights into the antifibrotic effects of sorafenib on hepatic stellate cells and liver fibrosis.

Wang Y, Gao J, Zhang D, Zhang J, Ma J, Jiang H.

J Hepatol. 2010 Jul;53(1):132-44. doi: 10.1016/j.jhep.2010.02.027. Epub 2010 Apr 13.

PMID:
20447716
11.

Inhibition of plasminogen activator inhibitor-1 expression by siRNA in rat hepatic stellate cells.

Hu PF, Zhu YW, Zhong W, Chen YX, Lin Y, Zhang X, Yin C, Yue HY, Xie WF.

J Gastroenterol Hepatol. 2008 Dec;23(12):1917-25. doi: 10.1111/j.1440-1746.2008.05485.x. Epub 2008 Aug 28.

PMID:
18761555
12.

The Salvia miltiorrhiza monomer IH764-3 induces apoptosis of hepatic stellate cells in vivo in a bile duct ligation-induced model of liver fibrosis.

Liu L, Wei J, Huo X, Fang S, Yao D, Gao J, Jiang H, Zhang X.

Mol Med Rep. 2012 Dec;6(6):1231-8. doi: 10.3892/mmr.2012.1076. Epub 2012 Sep 11.

PMID:
22971838
13.
14.

Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro.

Galli A, Crabb DW, Ceni E, Salzano R, Mello T, Svegliati-Baroni G, Ridolfi F, Trozzi L, Surrenti C, Casini A.

Gastroenterology. 2002 Jun;122(7):1924-40.

PMID:
12055599
15.

Ribozymes against TGFbeta1 reverse character of activated hepatic stellate cells in vitro and inhibit liver fibrosis in rats.

Song YH, Chen XL, Kong XJ, Liu NZ, Li W, Wu XL, Lin JS, Jin YX.

J Gene Med. 2005 Jul;7(7):965-76.

PMID:
15772939
16.
17.

NP603, a novel and potent inhibitor of FGFR1 tyrosine kinase, inhibits hepatic stellate cell proliferation and ameliorates hepatic fibrosis in rats.

Lin N, Chen S, Pan W, Xu L, Hu K, Xu R.

Am J Physiol Cell Physiol. 2011 Aug;301(2):C469-77. doi: 10.1152/ajpcell.00452.2010. Epub 2011 May 4.

18.

Role of endogenous opioids in modulating HSC activity in vitro and liver fibrosis in vivo.

De Minicis S, Candelaresi C, Marzioni M, Saccomano S, Roskams T, Casini A, Risaliti A, Salzano R, Cautero N, di Francesco F, Benedetti A, Svegliati-Baroni G.

Gut. 2008 Mar;57(3):352-64. Epub 2007 Nov 7.

PMID:
17989109
19.

RNA interference targeting the platelet-derived growth factor receptor beta subunit ameliorates experimental hepatic fibrosis in rats.

Chen SW, Zhang XR, Wang CZ, Chen WZ, Xie WF, Chen YX.

Liver Int. 2008 Dec;28(10):1446-57. doi: 10.1111/j.1478-3231.2008.01759.x. Epub 2008 May 3.

20.

Hepatic stellate cell-targeted delivery of M6P-HSA-glycyrrhetinic acid attenuates hepatic fibrogenesis in a bile duct ligation rat model.

Luk JM, Zhang QS, Lee NP, Wo JY, Leung PP, Liu LX, Hu MY, Cheung KF, Hui CK, Lau GK, Fan ST.

Liver Int. 2007 May;27(4):548-57.

PMID:
17403195

Supplemental Content

Support Center